Loading...

Danaher Corporation

DHR-PBNYSE
Healthcare
Medical - Diagnostics & Research
$1261.26
$-9.94(-0.78%)

Danaher Corporation (DHR-PB) Stock Overview

Explore Danaher Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 70.2/100

Key Financials

Market Cap916.8B
P/E Ratio43.01
EPS (TTM)$8.64
ROE0.07%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$889.17

DHR-PB Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Danaher Corporation (DHR-PB) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $889.17.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 43.01 and a market capitalization of 916.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;